Endometrial hyperplasia screening
|
Endometrial hyperplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial hyperplasia screening On the Web |
|
American Roentgen Ray Society Images of Endometrial hyperplasia screening |
|
Risk calculators and risk factors for Endometrial hyperplasia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Soujanya Thummathati, MBBS [3]
Oveview
Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended.
Screening
- Women receiving unopposed estrogens need endometrial sampling once every 2 years (relative risk increases only after 2 years of estrogen use), particularly if endometrial hyperstimulation has been documented previously and has not been treated by short-term administration of progestins. [1]
- Also, if the informed, high-risk individual requests an endometrial evaluation before or during HRT or at any time during her periodic health examinations, she should not be deprived of an office-based investigative procedure to rule out endometrial pathology.
- An endometrial evaluation also should be performed in women at high risk for endometrial carcinoma, such as women with history of Lynch II syndrome.